Search results for: 'deaco captura scienc 2004'
- Did you mean
- deal captura scienc 2024
- Related search terms
- deaco+and+alliance
- 2004 deal alliances review
- 2004 deaf alliance review
- 2004 denali alliance review
- scienc+cross+partnering+221b+221b
-
Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024October 2024$3,995.00Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Licensing Deals in Biotechnology 2019-2024September 2024$3,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Global Specialty Pharmaceutical Partnering Terms and Agreements 2019-2024October 2024$3,995.00Global Specialty Pharmaceutical Partnering Terms and Agreements 2019 to 2024 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Joint Venture Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Drug Delivery Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2019-2024November 2024$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
